CelLBxHealth plc (ANPCF)

OTCMKTS · Delayed Price · Currency is USD

0.0168

-0.0029 (-14.72%)

At close: Nov 25, 2025

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Millions GBX. Fiscal year is Jan - Dec.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016	Apr '15 Apr 30, 2015
Product	1.23M
Product Growth	106.90%
Pharma Services	756.00K
Pharma Services Growth	125.67%
Product Services	201.00K
Product Services Growth	79.46%

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Millions GBX. Fiscal year is Jan - Dec.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016	Apr '15 Apr 30, 2015
Europe	741.00K
Europe Growth	59.01%
United Kingdom	506.00K
United Kingdom Growth	128.96%
North America	503.00K
North America Growth	42.09%
Rest of World	436.00K